itan-Biotech, LLC is developing novel cancer diagnostic devices, platforms for glycan biomarker discovery, and disposable biosensors for pathogen detection, including assay development services. Headed up principals with expertise in surface chemistry, bioanalytical chemistry, analytical chemistry, molecular biology and microelectronics engineering, the firm is working on biochips for detecting multiple serum cytokines and cancer biomarkers; Point-of-care devices for Circulating Tumor Cells (CTCs) isolation and detection; Impedance biosensors for rapid infection detection and High throughput glycan analysis platforms.
